75g oral glucose tolerance test (OGTT)
OtherAll these women underwent the 75g oral glucose tolerance test (OGTT) at 24-28 weeks of gestation.
NCT Number: NCT02555332
This study was conducted to analyze the role of TSH level and TPOAb status in early pregnancy and use this information in assessment of the risk of gestational diabetes mellitus at different weeks of gestation when the FT4 level is normal.
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
A total of 7,729 women with singleton pregnancies who were receiving antenatal care at Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine between December 2012 and March 2014 were included in the study. All these women underwent screening for thyroid function (TSH,FT4 and TPOAb) at the first antenatal visit and a 75 g oral glucose tolerance test at 24-28 weeks of gestation. The correlation between a combination of TSH level and TPOAb status and the risk of gestational diabetes mellitus was analyzed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Criteria:
Inclusion criteria
Exclusion criteria
All these women underwent the 75g oral glucose tolerance test (OGTT) at 24-28 weeks of gestation.
Time frame: 24-28 weeks
Shanghai First Maternity and Infant Hospital
Other
Maternal TSH Level and TPOAb Status in Early Pregnancy and Their Relationship to the Risk of Gestational Diabetes Mellitus
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01922791
Adiposity, Behavior
Turku, Finland
View Trial DetailsNCT02926079
Diabetes Mellitus, Diabetes, Gestational
Baton Rouge, Louisiana, United States
View Trial DetailsNCT02508844
Body Weight, Diabetes Mellitus
Hvidovre, Copenhagen, Denmark
View Trial DetailsNCT02035059
Diabetes Insipidus, Diabetes Mellitus
Basel, Canton of Basel-City, Switzerland
View Trial Details